The IHC markers are Estrogen receptor (ER, Progesterone receptor (PR), Human Epidermal Growth Factor (HER2) that give clear indications of the presence of cancer cells in the tissue sample. HER2 remains the most reliable marker for the detection of breast cancer. The Human Epidermal Growth ...
The presence of estrogen receptors (ERs), as detected by immunohistochemistry (IHC), is a weak prognostic marker of clinical outcome in breast cancer, but a strong predictive marker for response, for example, to tamoxifen-based therapy. As with all IHC markers, factors such as tissue fixation ...
immunohistochemistry Prognostic and predictive markers Antibody-defined markers in breast cancer can be employed in two different ways: as prognostic markers (those that can independently forecast clinical outcome) and as predictive markers (those that can independently predict response to a particular thera...
Reference: The Use of Immunohistochemistry for Diagnosis of Prostate Cancer, Katia R. M. Leite, et al. Cancer markers ALK gene rearrangements Cancer types: Non-small cell lung cancer and anaplastic large cell lymphoma Tissue analyzed: Tumor ...
Introduction To investigate the predictive value of clinical and biological markers for a pathological complete remission after a preoperative dose-dense r... MG Von,HP Sinn,G Raab,... - Breast Cancer Research,10,2(2008-04-01) 被引量: 232发表: 2008年 CEA Monitoring Among Patients in Multi...
The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines The molecular classification for breast carcinomas has been used in clinical studies with a simple surrogate panel of immunohistochemistry (IHC) markers. T... Kristina...
在一些 实施方式中,所述癌症或肿瘤可以是乳腺癌或乳癌(参见例如,Dowsett,M等人,JNCI,第103 卷,第2期,2011年11月16日)、头颈癌(参见例如,Ahmed等人,Int J Biol Markers.2016年5 月28日;31(2):193‑203)、结直肠癌(参见例如,Li等人,Mol Med Rep.2015年3月;11(3): 1566‑72)、膀胱癌(参见例如,...
Evaluation of factors related to late recurrence--later than 10 years after the initial treatment--in primary breast cancer. Treatment decisions for breast cancer are commonly based on the information derived from the immunohistochemistry (IHC) of biological markers. The common ... R Nishimura,T Os...
Most oestrogen receptor (ER)-positive early breast cancer diagnosed today is highly curable with multimodality treatment. Systemic adjuvant treatments including endocrine therapy and chemotherapy have made a significant contribution to the increasing cur
Cancer Collagens EMT Epigenetics Keratins Immunology Myosins Macrophage Markers Neuroscience Signaling Stem Cells Transcription Factors Others By tissue type: Adipose Tissue Breast Cervix Colon Colorectal Tissue Gastric Tissue Kidney Liver Lung Muscle Ovary Pancreas Prosta...